January 2, 2026 · Form 4 insider transaction
Giuffre Randall Michael bought 6,175 shares of DIAMEDICA THERAPEUTICS INC at $8.42 per share, a transaction worth $52.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.